Maximum Daily Dose of Paroxetine ER
The maximum recommended daily dose of paroxetine extended-release (ER) is 62.5 mg per day 1.
Dosing Information
The FDA-approved dosing range for paroxetine ER is 25-62.5 mg/day 1. This formulation was specifically developed to improve tolerability, particularly gastrointestinal side effects like nausea, compared to immediate-release paroxetine 2.
Standard Dosing Approach
- Starting dose: 25 mg once daily (typically in the morning)
- Therapeutic range: 25-62.5 mg/day
- Maximum dose: 62.5 mg/day
Comparison with Immediate-Release Formulation
For context, immediate-release paroxetine has a maximum dose of 50 mg/day for most psychiatric indications 3, 4. The FDA label notes that in OCD trials, doses up to 60 mg/day were studied, though the Physician's Desk Reference lists 60 mg as the upper limit 1.
Important Clinical Considerations
Dose-Response Relationship
Higher doses do not necessarily provide greater benefit. In fixed-dose studies for social anxiety disorder, the 20 mg/day dose showed clear efficacy, while 40 mg and 60 mg doses showed only trends for superiority without clear additional benefit 1, 5. The evidence suggests that 20 mg daily provides optimal benefit-to-risk ratio for most indications 6.
Nonlinear Pharmacokinetics
Paroxetine exhibits saturable metabolism through CYP2D6, meaning that doubling the dose results in more than double the plasma concentration 1. When increasing from 20 mg to 40 mg daily, plasma concentrations increase 2-3 times rather than simply doubling 1. This nonlinearity makes dose escalation above the standard therapeutic range particularly prone to adverse effects.
Special Populations Requiring Dose Reduction
- Elderly patients: Start at 50% of standard adult dose; maximum 40 mg/day for immediate-release 3, 4
- Renal impairment (CrCl <30 mL/min): Reduce initial dose; plasma concentrations approximately 4-fold higher 1
- Hepatic impairment: Reduce initial dose; plasma concentrations approximately 2-fold higher 1
- CYP2D6 poor metabolizers: May require only 25% of standard dose due to 3.8-fold higher drug exposure 7
Safety Concerns at Higher Doses
Exceeding recommended maximum doses increases risk of:
- Discontinuation syndrome (particularly with paroxetine due to short half-life) 3, 8
- Serotonin syndrome when combined with other serotonergic agents 8
- Sexual dysfunction and decreased libido (dose-related) 6
- QT prolongation (though this is more specifically noted with citalopram >40 mg/day) 8
Tapering from High Doses
If a patient has been on doses approaching or at the maximum, gradual tapering over 10-14 days is essential to minimize withdrawal symptoms 3. Recent evidence suggests even more gradual tapering may be needed for high-dose regimens 9.
Clinical Pitfall
Do not exceed 62.5 mg/day of paroxetine ER simply because a patient has not responded to lower doses. If inadequate response occurs at maximum therapeutic doses after an adequate trial (6-8 weeks), switching to a different antidepressant or adding augmentation strategies is more appropriate than further dose escalation 3.